8 Comments
⭠ Return to thread

you can't do this kind of analysis by hit frequency. People will share the link with relevant people and populations, so hits will always be biased towards what you are seeking. You need to find year over year data and look for a trend change

Expand full comment

Nah, when you also the French post-jab CJD facts, it supports the frequency analysis.

Abstract

Towards the emergence of a new form of the neurodegenerative Creutzfeldt-Jakob disease: Sixteen cases of CJD declared a few days after a COVID-19 “vaccine” Jab Jean Claude Perez, PhD Maths§Computer Science Bordeaux University ; Retired (IBM European Research center on Artificial Intelligence Montpellier France) ; Bordeaux metropole.

https://www.researchgate.net/publication/358661859_Towards_the_emergence_of_a_new_form_of_the_neurodegenerative_Creutzfeldt-Jakob_disease_Sixteen_cases_of_CJD_declared_a_few_days_after_a_COVID-19_vaccine_Jab

Expand full comment

Sorry the link is too old.

“IMO - There is some probability this paper may have cost La Montagnier his life. Just my opinion.

Towards the emergence of a new form of the neurodegenerative Creutzfeldt-Jakob disease: Sixteen cases of CJD declared a few days after a COVID-19 “vaccine” Jab

Authors La Montagnier, Claire Chalmin, Jean Claude Perez

Feb 2022

Expand full comment

this is much better evidence, thank you! RIP Dr. La Montagnier

Expand full comment

So it’s supports this article’s findings, non?

Expand full comment

I'm not saying it's not happening. I'm just saying that this way of arriving at frequency data is weak evidence. I was following Adam's work with interest before he got kicked from Twitter.

Expand full comment

This is the point, Pharma would have you believe that this happened by chance as if it was a randomly selected group. Assuming pharma's position is where you get those impossibly small odds. Ie Their jabs have nothing to do with this at all according to them.

Expand full comment

Exactly.

Expand full comment